IP Library Granted Patent US 12,214,149
Granted Patent B2
US 12,214,149 · App. 16/634,592 · Granted Feb 4, 2025

Applicator system containing a microneedle array which comprises an active ingredient for wound healing

Inventors: Stefan Henke (Kirchen, DE); Karsten Heuser (Bad Breisig, DE)
Assignee: LTS LOHMANN THERAPIE-SYSTEME AG
A61M37/0015A61K9/0021A61K31/164A61K31/17A61K31/728A61K36/63A61K36/886A61K38/39A61M2037/0023
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,214,149
App. No.
16/634,592
Granted
Feb 4, 2025
Kind
B2
Abstract

The invention relates to an applicator system comprising a microneedle array and to the use thereof for the intradermal delivery of active ingredients, and in particular of medicinal drugs, wherein this microneedle array is suitable for penetrating the skin of humans or animals and includes at least one active ingredient for wound healing.

Claims (25)

1. An applicator system comprising a microneedle array for use for the intradermal delivery of a first active ingredient, the applicator system comprising:

a plurality of microneedles on a carrier, wherein the microneedles are made of a polymer matrix in which at least one second active ingredient for wound healing is integrated or incorporated;

a trigger mechanism; and

at least one reservoir for storing the first active ingredient, the reservoir being in connection to the microneedles; and

wherein the first active ingredient is different from the at least one second active ingredient for wound healing, and the first active ingredient is a medicinal drug;

wherein the at least one second active ingredient for wound healing is selected from the group consisting of dexpanthenol, collagen, hyaluronic acid, and combinations thereof; and

wherein the polymer of the polymer matrix is selected from the group consisting of polylactides, polyglycolides, polylactide-co-glycolides, polyanhydrides, poly(ortho)esters, polyurethanes, polybutyric acids, polyvaleric acids, polylactide-co-caprolactones, polycarbonates, polyesters, polyvinyl chloride, polyacrylamides, cycloolefin (co)polymers, polymethacrylates, and thermoplastics.

2. The applicator system according to claim 1 , wherein the microneedle array is planar.

3. The applicator system according to claim 1 , wherein the density of the microneedles on a carrier is 5 to 5,000 pieces/cm 2 .

4. The applicator system according to claim 1 , wherein the at least one second active ingredient for wound healing is integrated or incorporated in the polymer matrix in an amount of 150 to 200 mg/cm 2 .

5. The applicator system according to claim 1 , wherein the microneedle array comprises fixation means.

6. The applicator system according to claim 1 , wherein the microneedle array comprises fixation means which is selected from the group consisting of adhesive strip, patch, band, elastic band, rubber and strap.

7. The applicator system according to claim 1 , wherein the first active ingredient is stored in the reservoir.

8. The applicator system according to claim 1 , wherein the reservoir is a flexible bag or a balloon.

9. The applicator system according to claim 1 , wherein the carrier is flexible and planar and the plurality of microneedles are integrated into the flexible planar carrier.

10. The applicator system according to claim 9 , wherein the applicator system comprises at least one reservoir containing the first active ingredient.

11. An applicator system comprising a microneedle array for the intradermal delivery of a first active ingredient, the applicator system comprising:

a plurality of microneedles on a carrier, wherein the microneedles are made of a polymer matrix in which at least one second active ingredient for wound healing is integrated or incorporated;

a trigger mechanism; and

at least one reservoir in connection with the microneedles; and

wherein the at least one reservoir contains the first active ingredient;

wherein the first active ingredient is different from the at least one second active ingredient for wound healing, and the first active ingredient is a medicinal drug;

wherein the at least one second active ingredient for wound healing is selected from the group consisting of dexpanthenol, collagen, hyaluronic acid, and combinations thereof; and

wherein the polymer of the polymer matrix is selected from the group consisting of polylactides, polyglycolides, polylactide-co-glycolides, polyanhydrides, poly(ortho)esters, polyurethanes, polybutyric acids, polyvaleric acids, polylactide-co-caprolactones, polycarbonates, polyesters, polyvinyl chloride, polyacrylamides, cycloolefin (co)polymers, polymethacrylates, and thermoplastics.

12. The applicator system according to claim 11 , wherein the reservoir is a flexible bag or a balloon.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2020
From: HENKE, STEFAN; HEUSER, KARSTEN
To: LTS LOHMANN THERAPIE-SYSTEME AG
Reel/Frame 054293/0228 →
Priority Claims (1)
DE 10 2017 117784.1 · Aug 4, 2017 · national
Continuity (1)
Related Publication 20200188649A1 · Jun 18, 2020
References Cited (22)
US 3964482A · Gerstel · 1976 [cited by examiner]
US 6611707B1 · Prausnitz · 2003 [cited by examiner]
US 20020128599A1 · Cormier · 2002 [cited by examiner]
US 20050203575A1 · Carson et al. · 2005 [cited by applicant]
US 20070066934A1 · Etheredge, III · 2007 [cited by examiner]
US 20070081977A1 · Horstmann · 2007 [cited by applicant]
US 20110319865A1 · Buss · 2011 [cited by applicant]
US 20140066843A1 · Zhang · 2014 [cited by examiner]
US 20140276366A1 · Bourne et al. · 2014 [cited by applicant]
US 20150057604A1 · Arami · 2015 [cited by examiner]
US 20170050010A1 · McAllister et al. · 2017 [cited by applicant]
US 20180099133A1 · Heuser et al. · 2018 [cited by applicant]
DE 10353629A1 · 2005 [cited by applicant]
EP 2578264A1 · 2013 [cited by applicant]
EP 2835147A1 · 2015 [cited by applicant]
WO WO2008053481A1 · 2008 [cited by applicant]
WO WO2008091602A2 · 2008 [cited by applicant]
WO 2013151044A1 · 2013 [cited by applicant]
WO WO2016162449A1 · 2016 [cited by applicant]
International Preliminary Examination Report for PCT/EP2018/071209 mailed Nov. 8, 2019. [cited by applicant]
International Search Report for PCT/EP2018/071209 mailed Nov. 22, 2018. [cited by applicant]
Written Opinion of the International Searching Authority for PCT/EP2018/071209 mailed Nov. 22, 2018. [cited by applicant]